Design and Validation of Liposomal ApoE2 Gene Delivery System to Evade Blood–Brain Barrier for Effective Treatment of Alzheimer’s Disease

Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems

Danaei, M., Dehghankhold, M., Ataei, S., Davarani, F. H., Javanmard, R., Dokhani, A., Khorasani, S., & Mozafari, M. R. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10020057 · Cited by 4,967 · see citing works

PEGylation as a strategy for improving nanoparticle-based drug and gene delivery

Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523 · see citing works

Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease

Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786 · see citing works

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459 · see citing works

The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles

Fröhlich, E. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s36111 · Cited by 2,496 · see citing works

Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes

Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,030 · see citing works

2018 Alzheimer's disease facts and figures

Alzheimer's Association (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.001 · Cited by 1,912 · see citing works

Alzheimer Mechanisms and Therapeutic Strategies

Huang, Y., & Mucke, L. (2012) · Cell · doi:10.1016/j.cell.2012.02.040 · Cited by 1,758 · see citing works

Alzheimer’s disease drug-development pipeline: Few candidates, frequent failures

Cummings, J. L., Morstorf, T., & Zhong, K. (2014) · Alzheimer's Research & Therapy · doi:10.1186/alzrt269 · Cited by 1,744 · see citing works

Astrocytes induce blood–brain barrier properties in endothelial cells

Janzer, R. C., & RAFF, M. C. (1987) · Nature · doi:10.1038/325253a0 · Cited by 1,613 · see citing works

Human ApoE isoforms differentially regulate brain amyloid-β peptide clearance

Castellano, J. M., Kim, J., Stewart, F. R., Jiang, H., DeMattos, R. B., Patterson, B. W., Fagan, A. M., Morris, J. C., Mawuenyega, K. G., Cruchaga, C., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002156 · Cited by 1,227 · see citing works

Gene therapy returns to centre stage

Naldini, L. (2015) · Nature · doi:10.1038/nature15818 · Cited by 1,184 · see citing works

Increased Risk of Type 2 Diabetes in Alzheimer Disease

Janson, J., Laedtke, T., Parisi, J. E., O’Brien, P., Petersen, R. C., & Butler, P. C. (2004) · Diabetes · doi:10.2337/diabetes.53.2.474 · Cited by 950 · see citing works

Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer’s disease

Mahley, R. W., Weisgraber, K. H., & Huang, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600549103 · Cited by 912 · see citing works

ApoE Promotes the Proteolytic Degradation of Aβ

Jiang, Q., Lee, C. Y. D., Mandrekar, S., Wilkinson, B., Cramer, P., Zelcer, N., Mann, K., Lamb, B., Willson, T. M., Collins, J. L., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.010 · Cited by 876 · see citing works

Viral and nonviral delivery systems for gene delivery

Nouri, N., Talebi, M., & Ali, P. (2012) · Advanced Biomedical Research · doi:10.4103/2277-9175.98152 · Cited by 861 · see citing works

Apolipoprotein E in Alzheimer’s disease and other neurological disorders

Verghese, P. B., Castellano, J. M., & Holtzman, D. M. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70325-2 · Cited by 857 · see citing works

In vitro models of the blood–brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use

Helms, H. C., Abbott, N. J., Burek, M., Cecchelli, R., Couraud, P.-O., Deli, M. A., Förster, C., Galla, H. J., Romero, I. A., Shusta, E. V., et al. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16630991 · Cited by 843 · see citing works

Biocompatibility of engineered nanoparticles for drug delivery

Naahidi, S., Jafari, M., Edalat, F., Raymond, K. P., Khademhosseini, A., & Chen, P. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.12.013 · Cited by 814 · see citing works

Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study.

Butt, A. M., Jones, H. C., & Abbott, N. J. (1990) · The Journal of Physiology · doi:10.1113/jphysiol.1990.sp018243 · Cited by 775 · see citing works

apoE isoform–specific disruption of amyloid β peptide clearance from mouse brain

Deane, R., Sagare, A., Hamm, K., Parisi, M., Lane, S., Finn, M. B., Holtzman, D. M., & Zlokovic, B. V. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36663 · Cited by 771 · see citing works

Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB)

Booth, R., & Kim, H. (2012) · Lab on a Chip · doi:10.1039/c2lc40094d · Cited by 746 · see citing works

Parameters influencing the stealthiness of colloidal drug delivery systems

Vonarbourg, A., Passirani, C., Saulnier, P., & Benoit, J.-P. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.03.039 · Cited by 740 · see citing works

A new blood–brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes

Nakagawa, S., Deli, M. A., Kawaguchi, H., Shimizudani, T., Shimono, T., Kittel, Á., Tanaka, K., & Niwa, M. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2008.12.002 · Cited by 728 · see citing works

APOE and Alzheimer disease: a major gene with semi-dominant inheritance

Genin, E., Hannequin, D., Wallon, D., Sleegers, K., Hiltunen, M., Combarros, O., Bullido, M. J., Engelborghs, S., De Deyn, P., Berr, C., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.52 · Cited by 714 · see citing works

Cell-penetrating peptides: breaking through to the other side

Koren, E., & Torchilin, V. P. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.04.012 · Cited by 671 · see citing works

Anti‐ <scp>PEG</scp> immunity: emergence, characteristics, and unaddressed questions

Yang, Q., & Lai, S. K. (2015) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1339 · Cited by 593 · see citing works

Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: The CERAD experience, part XV

Ellis, R. J., Olichney, J. M., Thal, L. J., Mirra, S. S., Morris, J. C., Beekly, D., & Heyman, A. (1996) · Neurology · doi:10.1212/wnl.46.6.1592 · Cited by 561 · see citing works

Electrical resistance of brain microvascular endothelium

Crone, C., & Olesen, S. P. (1982) · Brain Research · doi:10.1016/0006-8993(82)91227-6 · Cited by 491 · see citing works

Nanoparticles evading the reticuloendothelial system: Role of the supported bilayer

Li, S., & Huang, L. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.06.022 · Cited by 487 · see citing works

Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals

Ying, X., Wen, H., Lü, W.-L., Du, J., Guo, J., Tian, W. J., Men, Y., Zhang, Y., Li, R., Yang, T., et al. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.09.020 · Cited by 448 · see citing works

Apolipoprotein E, Receptors, and Modulation of Alzheimer’s Disease

Zhao, N., Liu, C.-C., Qiao, W., & Bu, G. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.03.003 · Cited by 370 · see citing works

Biosynthesis and processing of endogenous BDNF: CNS neurons store and secrete BDNF, not pro-BDNF

Matsumoto, T., Rauskolb, S., Polack, M., Klose, J., Kolbeck, R., Körte, M., & Barde, Y. (2008) · Nature Neuroscience · doi:10.1038/nn2038 · Cited by 355 · see citing works

Astrocyte-mediated induction of tight junctions in brain capillary endothelium: an efficient in vitro model

Arthur, F. E., Shivers, R. R., & Bowman, P. D. (1987) · Developmental Brain Research · doi:10.1016/0165-3806(87)90075-7 · Cited by 345 · see citing works

The effects of aging on gene expression in the hypothalamus and cortex of mice

Jiang, C. H., Tsien, J. Z., Schultz, P. G., & Hu, Y. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1930 · Cited by 318 · see citing works

Apolipoprotein E–dependent accumulation of Alzheimer disease–related lesions begins in middle age

Kok, E., Haikonen, S., Luoto, T., Huhtala, H., Goebeler, S., Haapasalo, H., & Karhunen, P. J. (2009) · Annals of Neurology · doi:10.1002/ana.21696 · Cited by 299 · see citing works

Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells

Brown, R. C., Morris, A. P., & O'Neil, R. G. (2007) · Brain Research · doi:10.1016/j.brainres.2006.10.083 · Cited by 291 · see citing works

APOE ε4 lowers age at onset and is a high risk factor for Alzheimer's disease; A case control study from central Norway

Sando, S. B., Melquist, S., Cannon, A., Hutton, M. L., Sletvold, O., Saltvedt, I., White, L. R., Lydersen, S., & Aasly, J. O. (2008) · BMC Neurology · doi:10.1186/1471-2377-8-9 · Cited by 261 · see citing works

Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease

Nagy, Z. S., Esiri, M. M., Jobst, K. A., Johnston, C., Litchfield, S., Sim, E., & Smith, A. D. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00331-c · Cited by 250 · see citing works

Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier

Kim, J., Choi, W. I., Kim, Y. H., & Tae, G. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.047 · Cited by 219 · see citing works

Vectors and delivery systems in gene therapy.

Gardlík, R., Pálffy, R., Hodosy, J., Lukács, J., Turňa, J., & Celec, P. (2005) · PubMed · Cited by 219 · see citing works

Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems

Tsuji, A. (2004) · NeuroRx · doi:10.1602/neurorx.2.1.54 · Cited by 209 · see citing works

The Pharmacokinetics of Cell-Penetrating Peptides

Sarko, D., Beijer, B., Boy, R. G., Nothelfer, E.-M., Leotta, K., Eisenhut, M., Altmann, A., Haberkorn, U., & Mier, W. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100223d · Cited by 199 · see citing works

APOE2 enhances neuroprotection against Alzheimer’s disease through multiple molecular mechanisms

Conejero-Goldberg, C., Gomar, J. J., Bobes-Bascaran, T., Hyde, T. M., Kleinman, J. E., Herman, M. M., Chen, S., Davies, P., & Goldberg, T. E. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.194 · Cited by 199 · see citing works

Penetratin-functionalized PEG–PLA nanoparticles for brain drug delivery

Xia, H., Gao, X., Gu, G., Liu, Z., Hu, Q., Tu, Y., Song, Q., Yao, L., Pang, Z., Jiang, X., et al. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.029 · Cited by 161 · see citing works

Dual functionalized liposomes for efficient co-delivery of anti-cancer chemotherapeutics for the treatment of glioblastoma

Lakkadwala, S., dos Santos Rodrigues, B., Sun, C., & Singh, J. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.06.033 · Cited by 160 · see citing works

Middle-aged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks.

Bour, A., Grootendorst, J., Vogel, E., Kelche, C., Dodart, J.-C., Bales, K., Moreau, P.-H., Sullivan, P. M., & Mathis, C. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.05.008 · Cited by 141 · see citing works

Liposome targeting to mouse brain: Mannose as a recognition marker

Umezawa, F., & Yoshikatsu, E. T. O. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81333-0 · Cited by 140 · see citing works

Challenges in Realizing Selectivity for Nanoparticle Biodistribution and clearance: Lessons From Gold Nanoparticles

Haute, D. V., & Berlin, J. M. (2017) · Therapeutic Delivery · doi:10.4155/tde-2017-0057 · Cited by 138 · see citing works

Interaction of Nascent ApoE2, ApoE3, and ApoE4 Isoforms Expressed in Mammalian Cells with Amyloid Peptide β (1−40). Relevance to Alzheimer's Disease

Aleshkov, S., Abraham, C. R., & Zannis, V. I. (1997) · Biochemistry · doi:10.1021/bi9626362 · Cited by 138 · see citing works

Young APOE4 targeted replacement mice exhibit poor spatial learning and memory, with reduced dendritic spine density in the medial entorhinal cortexPreprint

Rodriguez, G. A., Burns, M. P., Weeber, E. J., & Rebeck, G. W. (2013) · Learning & Memory · doi:10.1101/lm.030031.112 · Cited by 134 · see citing works

Gene therapy: progress and predictions

Collins, M. K., & Thrasher, A. J. (2015) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2014.3003 · Cited by 133 · see citing works

Immortalized human cerebral microvascular endothelial cells maintain the properties of primary cells in an in vitro model of immune migration across the blood brain barrier

Daniels, B. P., Cruz‐Orengo, L., Pasieka, T. J., Couraud, P., Romero, I. A., Weksler, B. B., Cooper, J. A., Doering, T. L., & Klein, R. S. (2012) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2012.10.001 · Cited by 128 · see citing works

Cationic Liposomes Carrying siRNA: Impact of Lipid Composition on Physicochemical Properties, Cytotoxicity and Endosomal Escape

Lechanteur, A., Sanna, V., Duchemin, A., Évrard, B., Mottet, D., & Piel, G. (2018) · Nanomaterials · doi:10.3390/nano8050270 · Cited by 119 · see citing works

Dual functionalized liposome-mediated gene delivery across triple co-culture blood brain barrier model and specific in vivo neuronal transfection

dos Santos Rodrigues, B., Oue, H., Banerjee, A., Kanekiyo, T., & Singh, J. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.07.043 · Cited by 116 · see citing works

An Improved In Vitro Blood–Brain Barrier Model: Rat Brain Endothelial Cells Co-cultured with Astrocytes

Abbott, N. J., Dolman, D. E. M., Drndarski, S., & Fredriksson, S. M. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-452-0_28 · Cited by 110 · see citing works

Pentosan polysulfate protects brain endothelial cells against bacterial lipopolysaccharide-induced damages

Veszelka, S., Pásztói, M., Farkas, A. E., Krizbai, I. A., Dung, N. T. K., Niwa, M., Ábrahám, C. S., & Deli, M. A. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.08.006 · Cited by 110 · see citing works

GLUT-1: An Effective Target To Deliver Brain-Derived Neurotrophic Factor Gene Across the Blood Brain Barrier

Arora, S., Sharma, D., & Singh, J. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00076 · Cited by 107 · see citing works

Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes

Rosada, R. S., de la Torre, L. G., Frantz, F. G., Trombone, A. P. F., Zárate-Bladés, C. R., da Fonseca, D. M., Souza, P., Brandão, I. T., Masson, A. P., Soares, E. G., et al. (2008) · BMC Immunology · doi:10.1186/1471-2172-9-38 · Cited by 105 · see citing works

Porous silicon–graphene oxide core–shell nanoparticles for targeted delivery of siRNA to the injured brain

Joo, J., Kwon, E. J., Kang, J., Skalak, M., Anglin, E. J., Mann, A. P., Ruoslahti, E. I., Bhatia, S. N., & Sailor, M. J. (2016) · Nanoscale Horizons · doi:10.1039/c6nh00082g · Cited by 99 · see citing works

Immortalized endothelial cell lines for in vitro blood–brain barrier models: A systematic review

Rahman, N. A., Rasil, A. N. H. M., Meyding‐Lamadé, U., Craemer, E. M., Diah, S., Tuah, A. A., & Muharram, S. H. (2016) · Brain Research · doi:10.1016/j.brainres.2016.04.024 · Cited by 97 · see citing works

The Role of Cell-Penetrating Peptide and Transferrin on Enhanced Delivery of Drug to Brain

Sharma, G., Lakkadwala, S., Modgil, A., & Singh, J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060806 · Cited by 95 · see citing works

Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties

Rodrigues, B. D. S., Lakkadwala, S., Kanekiyo, T., & Singh, J. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s215941 · Cited by 95 · see citing works

Synthesis and Characterization of Fatty Acid Grafted Chitosan Polymer and Their Nanomicelles for Nonviral Gene Delivery Applications

Sharma, D., & Singh, J. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00505 · Cited by 95 · see citing works

Influence of Short-Chain Cell-Penetrating Peptides on Transport of Doxorubicin Encapsulating Receptor-Targeted Liposomes Across Brain Endothelial Barrier

Sharma, G., Modgil, A., Zhong, T., Sun, C., & Singh, J. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1242-x · Cited by 87 · see citing works

ApoE-2 Brain-Targeted Gene Therapy Through Transferrin and Penetratin Tagged Liposomal Nanoparticles

Rodrigues, B. D. S., Kanekiyo, T., & Singh, J. (2019) · Pharmaceutical Research · doi:10.1007/s11095-019-2691-7 · Cited by 81 · see citing works

Grafting of Cell-Penetrating Peptide to Receptor-Targeted Liposomes Improves their Transfection Efficiency and Transport across Blood–Brain Barrier Model

Sharma, G., Modgil, A., Sun, C., & Singh, J. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23152 · Cited by 80 · see citing works

Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials

Kim, J., Kim, P.-H., Kim, S. W., & Yun, C. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.020 · Cited by 79 · see citing works

Efficient neuronal targeting and transfection using RVG and transferrin-conjugated liposomes

Rodrigues, B. D. S., Arora, S., Kanekiyo, T., & Singh, J. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146738 · Cited by 74 · see citing works

Targeting Caspase-3 as Dual Therapeutic Benefits by RNAi Facilitating Brain-Targeted Nanoparticles in a Rat Model of Parkinson’s Disease

Liu, Y., Guo, Y., An, S., Kuang, Y., He, X., Ma, H., Li, J., Lv, J., Zhang, N., & Jiang, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062905 · Cited by 71 · see citing works

Hexanoic Acid and Polyethylene Glycol Double Grafted Amphiphilic Chitosan for Enhanced Gene Delivery: Influence of Hydrophobic and Hydrophilic Substitution Degree

Layek, B., Haldar, M. K., Sharma, G., Lipp, L., Mallik, S., & Singh, J. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400633r · Cited by 65 · see citing works

Functionalized liposomal nanoparticles for efficient gene delivery system to neuronal cell transfection

Rodrigues, B. D. S., Banerjee, A., Kanekiyo, T., & Singh, J. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.06.026 · Cited by 62 · see citing works

Targeting Alzheimer's disease with gene and cell therapies

Loera‐Valencia, R., Piras, A., Ismail, M.-A.-M., Manchanda, S., Eyjolfsdottir, H., Saido, T. C., Johansson, J., Eriksdotter, M., Winblad, B. G., & Nilsson, P. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12759 · Cited by 57 · see citing works

Targeting with nanoparticles for the therapeutic treatment of brain diseases

Jin, G., Chakraborty, A., Lee, J., Knowles, J. C., & Kim, H. (2020) · Journal of Tissue Engineering · doi:10.1177/2041731419897460 · Cited by 55 · see citing works

Apolipoprotein E: Remarkable Protein Sheds Light on Cardiovascular and Neurological Diseases

Mahley, R. W. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.255695 · Cited by 53 · see citing works

Long-term glycemic control and prevention of diabetes complications in vivo using oleic acid-grafted-chitosan‑zinc-insulin complexes incorporated in thermosensitive copolymer

Sharma, D., & Singh, J. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.012 · Cited by 51 · see citing works

Modulation of angiotensin II binding sites in neuronal cultures by mineralocorticoids

Sumners, C., & Fregly, M. J. (1989) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1989.256.1.c121 · Cited by 45 · see citing works

Recombinant Single-Chain Antibody with the Trojan Peptide Penetratin Positioned in the Linker Region Enables Cargo Transfer Across the Blood–Brain Barrier

Škrlj, N., Drevenšek, G., Hudoklin, S., Romih, R., Šerbec, V. Č., & Dolinar, M. (2012) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-012-9962-7 · Cited by 44 · see citing works

Sulfur Nanoparticles with Novel Morphologies Coupled with Brain-Targeting Peptides RVG as a New Type of Inhibitor Against Metal-Induced Aβ Aggregation

Sun, J., Xie, W., Zhu, X., Xu, M., & Liu, J. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00312 · Cited by 33 · see citing works

Gene Therapy and Cell Reprogramming For the Aging Brain: Achievements and Promise

Pardo, J., Morel, G. R., Astiz, M., Schwerdt, J. I., Leon, M. L. D., Rodríguez, S. S., Hereñú, C. B., & Goya, R. G. (2014) · Current Gene Therapy · doi:10.2174/1566523214666140120121733 · Cited by 20 · see citing works

Controlled Delivery of Salmon Calcitonin Using Thermosensitive Triblock Copolymer Depot for Treatment of Osteoporosis

Lipp, L., Sharma, D., Banerjee, A., & Singh, J. (2019) · ACS Omega · doi:10.1021/acsomega.8b02781 · Cited by 19 · see citing works

Chitosan-Based Systems for Gene Delivery

Sharma, D., Arora, S., Rodrigues, B. D. S., Lakkadwala, S., Banerjee, A., & Singh, J. (2019) · Springer eBooks · doi:10.1007/978-981-15-0263-7_8 · Cited by 18 · see citing works

Smart thermosensitive copolymer incorporating chitosan–zinc–insulin electrostatic complexes for controlled delivery of insulin: effect of chitosan chain length

Sharma, D., Arora, S., & Singh, J. (2019) · International Journal of Polymeric Materials · doi:10.1080/00914037.2019.1655750 · Cited by 17 · see citing works

Chitosan for gene, DNA vaccines, and drug delivery

Rodrigues, B. D. S., Lakkadwala, S., Sharma, D., & Singh, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-818433-2.00015-7 · Cited by 16 · see citing works

Successful transfection of hepatoma cells after encapsulation of plasmid DNA into negatively charged liposomes

Zhang, H., Zhang, L., Sun, X., & Zhang, Z. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.21146 · Cited by 15 · see citing works

Alzheimer’s Disease

Puerto, A. M. H., Russo, C., & Fregni, F. (2018) · Neuromethods · doi:10.1007/978-1-4939-7880-9_9 · Cited by 3 · see citing works

A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics

Lamptey, R. N. L., Chaulagain, B., Trivedi, R., Gothwal, A., Layek, B., & Singh, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031851 · Cited by 958 · see citing works

A Comprehensive Review of Nanoparticles: From Classification to Application and Toxicity

Eker, F., Duman, H., Akdaşçi, E., Bolat, E., Sarıtaş, S., Karav, S., & Witkowska, A. M. (2024) · Molecules · doi:10.3390/molecules29153482 · Cited by 277 · see citing works

Nanomedicine: How nanomaterials are transforming drug delivery, bio-imaging, and diagnosis

Kurul, F., Turkmen, H., Çetin, A. E., & Topkaya, S. N. (2025) · Next Nanotechnology · doi:10.1016/j.nxnano.2024.100129 · Cited by 255 · see citing works

Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies

Pires, M., & Rego, A. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010778 · Cited by 157 · see citing works

Understanding Drug Delivery to the Brain Using Liposome-Based Strategies: Studies that Provide Mechanistic Insights Are Essential

Juhairiyah, F., & de Lange, E. C. M. (2021) · The AAPS Journal · doi:10.1208/s12248-021-00648-z · Cited by 158 · see citing works

Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases

Teixeira, M. I., Lopes, C. M., Amaral, M. H., & Costa, P. C. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112999 · Cited by 155 · see citing works

Recent Advances in the Treatment of Alzheimer’s Disease Using Nanoparticle-Based Drug Delivery Systems

Poudel, P., & Park, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040835 · Cited by 124 · see citing works

Recent advances in using liposomes for delivery of nucleic acid-based therapeutics

Nsairat, H., Alshaer, W., Odeh, F., Esawi, E., Khater, D., Bawab, A. A., El‐Tanani, M., Awidi, A., & Mubarak, M. S. (2023) · OpenNano · doi:10.1016/j.onano.2023.100132 · Cited by 107 · see citing works

Altered Metabolism in Alzheimer Disease Brain: Role of Oxidative Stress

Rummel, N. G., & Butterfield, D. A. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0177 · Cited by 105 · see citing works

Endothelial Dysfunction in Neurodegenerative Diseases

Fang, Y., Hsieh, Y., Hu, C., & Tu, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032909 · Cited by 101 · see citing works

A review of the tortuous path of nonviral gene delivery and recent progress

Sharma, D., Arora, S., Singh, J., & Layek, B. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.05.192 · Cited by 93 · see citing works

Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges

Parrasia, S., Szabó, I., Zoratti, M., & Biasutto, L. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00523 · Cited by 90 · see citing works

Enhancing autophagy in Alzheimer's disease through drug repositioning

Eshraghi, M., Ahmadi, M., Afshar, S., Lorzadeh, S., Adlimoghaddam, A., Rezvani Jalal, N., West, R., Dastghaib, S., Igder, S., Torshizi, S. R. N., et al. (2022) · Pharmacology &amp; Therapeutics · doi:10.1016/j.pharmthera.2022.108171 · Cited by 89 · see citing works

Levodopa-loaded nanoparticles for the treatment of Parkinson's disease

van Vliet, E. F., Knol, M. J., Schiffelers, R. M., Caiazzo, M., & Fens, M. H. A. M. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.06.026 · Cited by 85 · see citing works

Nanomedicine: A Promising Way to Manage Alzheimer’s Disease

Khan, N. H., Mir, M., Ngowi, E. E., Zafar, U., Khakwani, M. M. A. K., Khattak, S., Zhai, Y., Jiang, E., Zheng, M., Duan, S., et al. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.630055 · Cited by 82 · see citing works

Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date

Witika, B. A., Poka, M., Demana, P. H., Matafwali, S. K., Melamane, S., Khamanga, S. M., & Makoni, P. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040836 · Cited by 82 · see citing works

Nanoparticle-Based Drug Delivery Systems: An Inspiring Therapeutic Strategy for Neurodegenerative Diseases

Duan, L., Li, X., Ji, R., Hao, Z., Kong, M., Wen, X., Guan, F., & Ma, S. (2023) · Polymers · doi:10.3390/polym15092196 · Cited by 78 · see citing works

The Nanocarrier Landscape─Evaluating Key Drug Delivery Vehicles and Their Capabilities: A Translational Perspective

Khalid-Salako, F. A., Khaligh, S. S., Fathi, F., Demirci, O. C., Öncer, N., Kurt, H., & Yüce, M. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c07366 · Cited by 76 · see citing works

Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer’s disease

Taliyan, R., Kakoty, V., Sarathlal, K. C., Kharavtekar, S. S., Karennanavar, C. R., Choudhary, Y. K., Singhvi, G., Riadi, Y., Dubey, S. K., & Kesharwani, P. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.044 · Cited by 76 · see citing works

Advances in dendrimer-mediated targeted drug delivery to the brain

Gauro, R., Nandave, M., Jain, V. K., & Jain, K. (2021) · Journal of Nanoparticle Research · doi:10.1007/s11051-021-05175-8 · Cited by 69 · see citing works

Functionalized nanoparticles for brain targeted BDNF gene therapy to rescue Alzheimer's disease pathology in transgenic mouse model

Arora, S., Kanekiyo, T., & Singh, J. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.03.203 · Cited by 68 · see citing works

Lipid Nanoparticles: Versatile Drug Delivery Vehicles for Traversing the Blood Brain Barrier to Treat Brain Cancer

Cai, X., Drummond, C. J., Zhai, J., & Tran, N. L. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202404234 · Cited by 72 · see citing works

Liposomes: An emerging carrier for targeting Alzheimer's and Parkinson's diseases

Pandian, S. R. K., Vijayakumar, K. K., Murugesan, S., & Kunjiappan, S. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09575 · Cited by 71 · see citing works

New Drug Delivery Systems Developed for Brain Targeting

Rawal, S. U., Patel, B. M., & Patel, M. M. (2022) · Drugs · doi:10.1007/s40265-022-01717-z · Cited by 65 · see citing works

Multifunctional Nanotheranostics for Overcoming the Blood–Brain Barrier

Beygi, M. H. M., Oroojalian, F., Azizi‐Arani, S., Hosseini, S. S., Mokhtarzadeh, A., Kesharwani, P., & Sahebkar, A. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202310881 · Cited by 65 · see citing works

Recent advances in Bio-conjugated nanocarriers for crossing the Blood-Brain Barrier in (pre-)clinical studies with an emphasis on vesicles

Poustforoosh, A., Nematollahi, M. H., Hashemipour, H., & Pardakhty, A. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.02.015 · Cited by 61 · see citing works

Advances on Therapeutic Strategies for Alzheimer’s Disease: From Medicinal Plant to Nanotechnology

Hassan, N. A., Alshamari, A. K., Hassan, A. A., Elharrif, M. G., Alhajri, A. M., Sattam, M., & Khattab, R. R. (2022) · Molecules · doi:10.3390/molecules27154839 · Cited by 64 · see citing works

Mechanistic insights and emerging therapeutic stratagems for Alzheimer’s disease

Rajendran, K., & Krishnan, U. M. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102309 · Cited by 58 · see citing works

Drug delivery strategies with lipid-based nanoparticles for Alzheimer’s disease treatment

Jang, Y.-J., Kang, S.-J., Park, H. S., Lee, D., Kim, J. H., Kim, J.-E., Kim, D., Chung, C., Yoon, J., & Bhang, S. H. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03109-3 · Cited by 62 · see citing works

The application of nanotechnology in treatment of Alzheimer’s disease

Cao, Y., & Zhang, R. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1042986 · Cited by 54 · see citing works

An Overview on the Physiopathology of the Blood–Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery

Susa, F., Arpicco, S., Pirri, C. F., & Limongi, T. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16070849 · Cited by 50 · see citing works

Cell-Penetrating Peptides: Promising Therapeutics and Drug-Delivery Systems for Neurodegenerative Diseases

Pirhaghi, M., Mamashli, F., Moosavi-Movahedi, F., Arghavani, P., Amiri, A., Davaeil, B., Mohammad-Zaheri, M., Mousavi-Jarrahi, Z., Sharma, D., Langel, Ü., et al. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c01167 · Cited by 46 · see citing works

How Precise are Nanomedicines in Overcoming the Blood–Brain Barrier? A Comprehensive Review of the Literature

Mohapatra, P., Gopikrishnan, M., Doss, C. G. P., & Chandrasekaran, N. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s442520 · Cited by 47 · see citing works

In vitro and in vivo optimization of liposomal nanoparticles based brain targeted vgf gene therapy

Arora, S., & Singh, J. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121095 · Cited by 44 · see citing works

Exosome-based approaches in the management of Alzheimer’s disease

Kandimalla, R., Saeed, M., Tyagi, N., Gupta, R. C., & Aqil, F. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104974 · Cited by 43 · see citing works

Advancements in the Application of Nanomedicine in Alzheimer’s Disease: A Therapeutic Perspective

Puranik, N., Yadav, D., & Song, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814044 · Cited by 44 · see citing works

Functionalized nanoparticles to deliver nucleic acids to the brain for the treatment of Alzheimer’s disease

Muolokwu, C. E., Chaulagain, B., Gothwal, A., Mahanta, A. K., Tagoe, B., Lamsal, B., & Singh, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1405423 · Cited by 42 · see citing works

Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review

Jalili, C., Kiani, A., Gholami, M., Bahrehmand, F., Fakhri, S., Kakehbaraei, S., & Kakebaraei, S. (2023) · IET Nanobiotechnology · doi:10.1049/nbt2.12127 · Cited by 42 · see citing works

A Promising Approach: Magnetic Nanosystems for Alzheimer’s Disease Theranostics

Chaparro, C. I. P., Simões, B. T., Borges, J. P., Castanho, M. A. R. B., Soares, P. I. P., & Neves, V. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092316 · Cited by 40 · see citing works

Extracellular vesicle-based delivery of silencing sequences for the treatment of Machado-Joseph disease/spinocerebellar ataxia type 3

Rufino‐Ramos, D., de Albuquerque, P. R., Leandro, K., Carmona, V., Martins, I. M., Fernandes, R., Henriques, C., Lobo, D. D., Faro, R., Perfeito, R., et al. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.04.001 · Cited by 39 · see citing works

Recent Progress in Nanomedicine for the Diagnosis and Treatment of Alzheimer’s Diseases

Yang, H., Tan, H., Wen, H., Xin, P., Liu, Y., Deng, Z., Xu, Y., Gao, F., Zhang, L., Ye, Z., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c11966 · Cited by 37 · see citing works

Utilization of nanotechnology to surmount the blood-brain barrier in disorders of the central nervous system

Luo, Q., Yang, J., Yang, M., Wang, Y., Liu, Y., Liu, J., Kalvakolanu, D. V., Cong, X., Zhang, J., Zhang, L., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101457 · Cited by 39 · see citing works

Nanoliposomes as safe and efficient drug delivery nanovesicles

Fatfat, Z., Karam, M., Maatouk, B. I., Fahs, D., & Gali‐Muhtasib, H. U. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91668-4.00002-2 · Cited by 33 · see citing works

Peptide-functionalized nanoparticles for brain-targeted therapeutics

Tang, S. N., Han, E. L., & Mitchell, M. J. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01840-w · Cited by 37 · see citing works

Next-Generation Drug Delivery for Neurotherapeutics: The Promise of Stimuli-Triggered Nanocarriers

Boyuklieva, R., Zahariev, N., Simeonov, P., Penkov, D., & Katsarov, P. (2025) · Biomedicines · doi:10.3390/biomedicines13061464 · Cited by 33 · see citing works

Glutathione- and apolipoprotein E-grafted liposomes to regulate mitogen-activated protein kinases and rescue neurons in Alzheimer's disease

Kuo, Y., Ng, I.-W., & Rajesh, R. (2021) · Materials Science and Engineering C · doi:10.1016/j.msec.2021.112233 · Cited by 32 · see citing works

Doxorubicin Delivered via ApoE-Directed Reduction-Sensitive Polymersomes Potently Inhibit Orthotopic Human Glioblastoma Xenografts in Nude Mice

Ouyang, J., Jiang, Y., Deng, C., Zhong, Z., & Lan, Q. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s314895 · Cited by 31 · see citing works

Multifunctionalized Cationic Chitosan Polymeric Micelles Polyplexed with pVGF for Noninvasive Delivery to the Mouse Brain through the Intranasal Route for Developing Therapeutics for Alzheimer’s Disease

Gothwal, A., Lamptey, R. N. L., & Singh, J. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00031 · Cited by 30 · see citing works

Bio–Nano Toolbox for Precision Alzheimer's Disease Gene Therapy

Liu, Y., Xia, X., Zheng, M., & Shi, B. (2024) · Advanced Materials · doi:10.1002/adma.202314354 · Cited by 30 · see citing works

Nanomedicine in Neuroprotection, Neuroregeneration, and Blood–Brain Barrier Modulation: A Narrative Review

Kršek, A., Jagodic, A., & Batičić, L. (2024) · Medicina · doi:10.3390/medicina60091384 · Cited by 28 · see citing works

Liposomes as versatile agents for the management of traumatic and nontraumatic central nervous system disorders: drug stability, targeting efficiency, and safety

Zhang, M., Xiang, C., Niu, R., He, X., Luo, W., Liu, W., & Gu, R. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00048 · Cited by 28 · see citing works

Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer’s disease?

Vecchio, F. L., Bisceglia, P., Imbimbo, B. P., Lozupone, M., Latino, R. R., Resta, E., Leone, M., Solfrizzi, V., Greco, A., Daniele, A., et al. (2022) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223221081605 · Cited by 28 · see citing works

Does the imbalance in the apolipoprotein E isoforms underlie the pathophysiological process of sporadic Alzheimer's disease?

Lozupone, M., Imbimbo, B. P., Balducci, C., Vecchio, F. L., Bisceglia, P., Latino, R. R., Leone, M. A., Dibello, V., Solfrizzi, V., Greco, A., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12728 · Cited by 26 · see citing works

Improved insulin sensitivity in obese-diabetic mice via chitosan Nanomicelles mediated silencing of pro-inflammatory Adipocytokines

Sharma, D., Arora, S., Banerjee, A., & Singh, J. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2020.102357 · Cited by 25 · see citing works

Advances in Antioxidant Nanomedicines for Imaging and Therapy of Alzheimer's Disease

Hasan, I., Guo, B., Zhang, J., & Chang, C. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0107 · Cited by 24 · see citing works

Brain Targeting Nanomedicines: Pitfalls and Promise

Käkinen, A., Jiang, Y., Davis, T. P., Teesalu, T., & Saarma, M. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s454553 · Cited by 24 · see citing works

Neurogenic Hypertension, the Blood–Brain Barrier, and the Potential Role of Targeted Nanotherapeutics

Lamptey, R. N. L., Sun, C., Layek, B., & Singh, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032213 · Cited by 23 · see citing works

Single and Multitarget Systems for Drug Delivery and Detection: Up-to-Date Strategies for Brain Disorders

Grosso, C., Silva, A., Delerue-Matos, C. M., & Barroso, M. F. (2023) · Pharmaceuticals · doi:10.3390/ph16121721 · Cited by 24 · see citing works

Apolipoprotein E in Alzheimer’s Disease: Focus on Synaptic Function and Therapeutic Strategy

Qu, L., Xu, S., Lan, Z., Fang, S., Xu, Y., & Zhu, X. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04449-1 · Cited by 22 · see citing works

Nucleic Acid–Based Therapeutics in Orphan Neurological Disorders: Recent Developments

Khorkova, O., Hsiao, J. H., & Wahlestedt, C. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.643681 · Cited by 21 · see citing works

Extending dual-targeting upper-limit in liposomal delivery of lithospermic acid B for Alzheimer's mitochondrial revitalization

Meng, R., Yang, X., Li, Y., & Zhang, Q. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.01.059 · Cited by 19 · see citing works

The Different Cellular Entry Routes for Drug Delivery Using Cell Penetrating Peptides

Okafor, M., Schmitt, D. A., Ory, S., Gasman, S., Hureau, C., Faller, P., & Vitale, N. (2025) · Biology of the Cell · doi:10.1111/boc.70012 · Cited by 18 · see citing works

Non-viral approaches for gene therapy and therapeutic genome editing across the blood–brain barrier

Xie, R., Wang, Y., Burger, J. C., Li, D., Zhu, M., & Gong, S. (2023) · Med-X · doi:10.1007/s44258-023-00004-0 · Cited by 20 · see citing works

Nanoliposomes as nonviral vectors in cancer gene therapy

Yildiz, Ş., Entezari, M., Paskeh, M. D. A., Mirzaei, S., Kalbasi, A., Zabolian, A., Hashemi, F., Hushmandi, K., Hashemi, M., Raei, M., et al. (2024) · MedComm · doi:10.1002/mco2.583 · Cited by 17 · see citing works

A comprehensive and updated review on the applications of vesicular drug delivery systems in treatment of brain disorders: A shelter against storms

Rajizadeh, M. A., Motamedy, S., Mir, Y., Akhgarandouz, F., Nematollahi, M. H., & Nezhadi, A. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105011 · Cited by 17 · see citing works

Mechanisms of high-density lipoprotein in regulating blood-brain barrier function: insights and implications

Zhu, P., Xiao, L., & Wang, Y. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00721-1 · Cited by 15 · see citing works

Gene Therapy: Towards a New Era of Medicine

Bhagat, M., Kamal, R., Sharma, J., Kaur, K., Sharma, A. K., Singh, T. G., Bhatia, R., & Awasthi, A. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-03010-6 · Cited by 14 · see citing works

Recent advances in nanomaterial-based brain-targeted delivery systems for glioblastoma therapy

Qu, M., Wang, Q., Wang, X., Tang, J., Dong, X., Zhao, C., & Guan, Q. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2503694 · Cited by 14 · see citing works

Cell-Penetrating Peptides-Mediated Therapeutic Agents Delivery into the Central Nervous System

Wei, Y., Bao, H., Wang, L., Cao, Y., Liu, Z., Zhu, X., Chen, T., Wu, A., & Li, J. (2024) · ACS Materials Letters · doi:10.1021/acsmaterialslett.4c00397 · Cited by 13 · see citing works

Synthesis and Characterization of Transferrin and Cell-Penetrating Peptide-Functionalized Liposomal Nanoparticles to Deliver Plasmid ApoE2 In Vitro and In Vivo in Mice

Muolokwu, C. E., Gothwal, A., Kanekiyo, T., & Singh, J. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00870 · Cited by 13 · see citing works

Brain-targeted delivery of losartan through functionalized liposomal nanoparticles for management of neurogenic hypertension

Lamptey, R. N. L., Sun, C., & Singh, J. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122841 · Cited by 12 · see citing works

Molecular imaging-guided diagnosis and treatment integration for brain diseases

Yu, D., Liu, M., Ding, Q., Wu, Y., Wang, T., Song, L., Li, X., Qian, K., Cheng, Z., Gu, M., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.123021 · Cited by 12 · see citing works

Cell-penetrating proteins and peptides as a promising theragnostic agent for neurodegenerative disorder

Pancholi, B., Choudhary, M. K., Kumar, M., Babu, R., Vora, L. K., Khatri, D. K., & Garabadu, D. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106816 · Cited by 12 · see citing works

Evolution of lipid nanoparticles as charioteers of Alzheimer's disease therapeutics

Chakraborty, B., Patel, G., Padhan, B., Das, J., & Patel, M. (2024) · Applied Materials Today · doi:10.1016/j.apmt.2024.102442 · Cited by 11 · see citing works

Advancing Nanomaterial-Based Strategies for Alzheimer’s Disease: A Perspective

Zhou, H., Yin, X., Zhang, G., Yang, Z., & Zhou, R. (2025) · JACS Au · doi:10.1021/jacsau.5c00002 · Cited by 14 · see citing works

A Review of Brain-Targeted Nonviral Gene-Based Therapies for the Treatment of Alzheimer’s Disease

Arora, S., Sharma, D., Layek, B., & Singh, J. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00611 · Cited by 11 · see citing works

Lipid-based Non-viral Vector: Promising Approach for Gene Delivery

Panday, A., Dixena, B., Jain, N. S., & Jain, A. K. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128324084240828084904 · Cited by 10 · see citing works

Nanotechnology-driven approaches for the early detection and targeted treatment of Alzheimer’s disease

Sharma, D. K. (2025) · Journal of drug targeting · doi:10.1080/1061186x.2025.2561788 · Cited by 10 · see citing works

Nanomedicine strategies for central nervous system (CNS) diseases

Nagri, S., Rice, O., & Chen, Y. (2023) · Frontiers in Biomaterials Science · doi:10.3389/fbiom.2023.1215384 · Cited by 9 · see citing works

Penetratin and Mannose-Functionalized Cannabidiol Lipid Nanoparticles Encapsulating the BDNF Gene Reduce Amyloid-Induced Inflammation

Chaulagain, B., & Singh, J. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00811 · Cited by 8 · see citing works

Advanced intranasal peptide delivery systems for improved management of Alzheimer's disease

Majie, A., Karmakar, V., Ghosh, A., Chakraborty, S., Apurva, A., Layek, B., & Gorain, B. (2025) · Biomaterials Advances · doi:10.1016/j.bioadv.2025.214474 · Cited by 7 · see citing works

Stress-induced regional characteristics of the blood-brain barrier

Zhou, M.-Y., Xie, F., Zhao, Y. F., Wang, X., Sun, Z., & Qian, L. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111548 · Cited by 7 · see citing works

Tau-aggregation inhibition: promising role of nanoencapsulated dietary molecules in the management of Alzheimer’s disease

Nagaraju, P. G., Ashwini, S., & G., P. P. C. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2092446 · Cited by 7 · see citing works

Biomaterial‐Based Gene Delivery to Central Nervous System Cells for the Treatment of Spinal Cord Injury

McGuire, T. K., Stasiewicz, M., Woods, I., Dervan, A. G., & O’Brien, F. J. (2023) · Advanced NanoBiomed Research · doi:10.1002/anbr.202300030 · Cited by 7 · see citing works

Innovative Genoceuticals in Human Gene Therapy Solutions: Challenges and Safe Clinical Trials of Orphan Gene Therapy Products

Sharma, R. K. (2023) · Current Gene Therapy · doi:10.2174/1566523223666230911120922 · Cited by 6 · see citing works

Drug Delivery for Neurological Disorders Using Nanotechnology

Nag, S., Bhatt, M., Ghosh, S., Dey, A., Paul, S., Dutta, S., Mohanto, S., Gowda, B. H. J., & Ahmed, M. G. (2023) · Springer eBooks · doi:10.1007/978-981-99-9510-3_7 · Cited by 6 · see citing works

Nanoparticles as an Encouraging Therapeutic Approach to Alzheimer’s Disease

Batko, J., Antosz, K., Nowakowska, H., Błażejewska, M., Kowalik, E. M., Beszłej, J. A., & Leszek, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167725 · Cited by 5 · see citing works

Extravaganza of Nanobiotechnology in the Diagnosis and Treatment of Dementia Patients

Bhattacharya, S. (2022) · Current Pharmaceutical Biotechnology · doi:10.2174/1385272827666221027103050 · Cited by 6 · see citing works

Overcoming the blood–brain barrier in Alzheimer's disease: translational perspectives on advanced drug delivery platforms

Roamcharern, N., & Yubolphan, R. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1810486 · Cited by 4 · see citing works

Selective neurodegeneration generated by intravenous α‐synuclein pre‐formed fibril administration is not associated with endogenous α‐synuclein levels in the rat brain

Kuan, W., Alfaidi, M., Horne, C. B., Vallin, B., Fox, S. E., Fazal, S. V., Williams‐Gray, C. H., & Barker, R. A. (2022) · Brain Pathology · doi:10.1111/bpa.13128 · Cited by 3 · see citing works

Controlled Drug Release Systems for Cerebrovascular Diseases

Martín‐Morales, C., Caspani, S., Desco, M., Sousa, C. T., & Gómez‐Gaviro, M. V. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202400239 · Cited by 4 · see citing works

A review of glucoregulatory hormones potentially applicable to the treatment of Alzheimer’s disease: mechanism and brain delivery

Amatya, R., Min, K. A., & Shin, M. C. (2022) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-022-00566-y · Cited by 4 · see citing works

Deciphering the role of nanocarrier-based nucleic acid delivery to the brain for the management of neurodegenerative disorders

Panigrahy, S., Sikder, A., Amulya, E., Shah, S., Khairnar, P., Saraf, S., & Srivastava, S. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105325 · Cited by 4 · see citing works

Nanoformulations targeting Alzheimer's disease

Kapoor, D. U., Sharma, D., Pathak, Y. V., Prajapati, B. G., & Satani, B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13205-6.00010-8 · Cited by 5 · see citing works

Intranasal delivery of pApoE2 via penetratin-mannose multi-functionalized chitosan polymeric micelles to the brain: Reduced total tau and phosphorylated tau burden in transgenic Alzheimer's mouse model

Gothwal, A., Muolokwu, C. E., Chaulagain, B., Mahanta, A. K., & Singh, J. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143542 · Cited by 3 · see citing works

Blood–brain barrier and nanovesicles for brain-targeting drug delivery

Omidi, Y., Omidian, H., Kwon, Y., & Castejon, A. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91865-7.00007-9 · Cited by 3 · see citing works

Rewiring Neuroimmunity: Nanoplatform Innovations for CNS Disease Therapy

Akbar, M. U., Guo, W., Shen, X. M., Fang, Y., Liu, Y., Wang, P., Elnathan, R., & Chen, Y. (2025) · Advanced Therapeutics · doi:10.1002/adtp.202500124 · Cited by 3 · see citing works

Liposomal and Nanomaterial-Based Strategies for Targeted Alzheimer’s Disease Therapy

Balagurusamy, B., Ganesan, V., Gopi, V., & Ilayaperumal, P. (2025) · ACS Omega · doi:10.1021/acsomega.5c05391 · Cited by 4 · see citing works

Functionalized biopolymer-based drug delivery systems: current status and future perspectives

Layek, B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821437-4.00020-7 · Cited by 3 · see citing works

Non-Invasive Intranasal Delivery of pApoE2: Effect of Multiple Dosing on the ApoE2 Expression in Mice Brain

Gothwal, A., Lamptey, R. N. L., Trivedi, R., Chaulagain, B., & Singh, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241613019 · Cited by 3 · see citing works

ApoE-2 Brain-Targeted Gene Therapy Through Transferrin and Penetratin Tagged Liposomal Nanoparticles

Rodrigues, B. D. S., Kanekiyo, T., & Singh, J. (2019) · Pharmaceutical Research · doi:10.1007/s11095-019-2691-7 · Cited by 81 · see citing works

Synthesis and Characterization of Transferrin and Cell-Penetrating Peptide-Functionalized Liposomal Nanoparticles to Deliver Plasmid ApoE2 In Vitro and In Vivo in Mice

Muolokwu, C. E., Gothwal, A., Kanekiyo, T., & Singh, J. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00870 · Cited by 13 · see citing works

Dual Functionalized Liposomes for Gene Delivery to Brain to Prevent and Treat Alzheimer’s Disease

Rodrigues, B. D. S. (2019) · NDSU Repository (North Dakota State University) · Cited by 1 · see citing works

GLUT-1 Targeted Gene Delivery to Brain for the Treatment of Alzheimer's Disease

Arora, S. (2022) · NDSU Repository (North Dakota State University) · doi:10.48655/10365/32524

GLUT-1: An Effective Target To Deliver Brain-Derived Neurotrophic Factor Gene Across the Blood Brain Barrier

Arora, S., Sharma, D., & Singh, J. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00076 · Cited by 107 · see citing works